Fact CheckerSign in

NCT07247877Enrolling by invitation

Research on Using Small-for-size Grafts for Auxiliary Liver Transplantation in the Treatment of Portal Hypertension

Innovative Technology Research on Using Small-for-size Grafts for Auxiliary Liver Transplantation in the Treatment of Portal Hypertension

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

The objective of this observational study is to compare the safety profile of auxiliary liver transplantation using small-for-size grafts with that of conventional liver transplantation and to evaluate the efficacy of this technique. The primary research question it seeks to investigate is: "What are the differences in safety and efficacy between auxiliary liver transplantation utilizing small-for-size grafts and conventional liver transplantation for the treatment of portal hypertension?"

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
396 (estimated)
First submitted
18 Nov 2025
Start date
1 Jan 2014
Primary completion date
31 Dec 2028
Lead sponsor
Zhi-Jun Zhu
NCT number
NCT07247877

What you commit to

  • Study type: Observational
  • Planned participants: 396
  • From 1 Jan 2014 to the primary completion date, 31 Dec 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Special surgical procedures such as dual-graft liver transplantation.
  • Special graft sources including domino liver transplantation.
  • Liver re-transplantation.

Other illness

  • Presence of contraindications to liver transplantation combined with malignant tumors.
  • Grade III or higher portal vein thrombosis.
  • Severe systemic diseases unrelated to the etiology or complications of portal hypertension.

Other

  • Rare liver-related anatomical variations.

Who the study is looking for

  • Age \> 14 years.
  • Presence of decompensated portal hypertension.
  • Meeting the indications for liver transplantation surgery.
  • International Normalized Ratio (INR) \< 2.4.
  • Scheduled to undergo orthotopic auxiliary partial liver transplantation or conventional liver transplantation.

Age in the registry: 14 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.